These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11866205)
1. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues. Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma. Kysela B; Siracký J; Redecha M; Bárdos A Neoplasma; 1990; 37(5):489-95. PubMed ID: 2234210 [TBL] [Abstract][Full Text] [Related]
3. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma. Punnonen R; Mattila J; Kuoppala T; Koivula T J Cancer Res Clin Oncol; 1993; 119(7):426-9. PubMed ID: 8491764 [TBL] [Abstract][Full Text] [Related]
4. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma]. Zhou XR; Du XG Zhonghua Fu Chan Ke Za Zhi; 1992 Sep; 27(5):278-80, 316. PubMed ID: 1298588 [TBL] [Abstract][Full Text] [Related]
5. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952 [TBL] [Abstract][Full Text] [Related]
6. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues. Takahashi Y Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis. Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations. Lindahl B; Alm P; Killander D; Långström E; Tropé C Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763 [TBL] [Abstract][Full Text] [Related]
9. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues. Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389 [TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia. Michael H; Kotylo PK; Mohr M; Roth LM Am J Clin Pathol; 1996 Jul; 106(1):22-8. PubMed ID: 8701927 [TBL] [Abstract][Full Text] [Related]
12. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma. Lindahl B; Willén R Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527 [TBL] [Abstract][Full Text] [Related]
13. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Chen TL; Luo I; Mikhail N; Rasková J; Raska K Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949 [TBL] [Abstract][Full Text] [Related]
14. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma. Henderson GS; Brown KA; Perkins SL; Abbott TM; Clayton F Mod Pathol; 1996 Apr; 9(4):430-8. PubMed ID: 8729985 [TBL] [Abstract][Full Text] [Related]
15. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma. Goodman A; Bell DA; Rice LW Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry. Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors]. Shimizu K Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study. Friberg LG; Norén H; Delle U Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025 [TBL] [Abstract][Full Text] [Related]
19. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry. Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693 [TBL] [Abstract][Full Text] [Related]
20. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]